Dexmedetomidine and Long-term Outcomes in Elderly Patients After Cardiac Surgery
Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
A retrospective study showed that intraoperative dexmedetomidine administration was
associated with decreased risk of 1-year mortality after cardiac surgery. In a previous
randomized controlled trial, 285 elderly patients undergoing cardiac surgery were randomized
to receive either perioperative dexmedetomidine or placebo (normal saline) administration.
The purpose of this 6-year follow-up study is to investigate whether perioperative
dexmedetomidine can improve long-term outcomes in those recruited elderly patients after
cardiac surgery.
Phase:
N/A
Details
Lead Sponsor:
Peking University First Hospital
Collaborator:
Chinese Academy of Medical Sciences, Fuwai Hospital